Home › Funds › St. Louis Financial Planners Asset Management, LLC › ABT
St. Louis Financial Planners Asset Management, LLC position in ABT
ABBOTT LABORATORIES · Health Care
St. Louis Financial Planners Asset Management, LLC reported holding 51,393 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$4.9M, representing 2.61% of its reported portfolio and ranking #9 among its reported holdings. St. Louis Financial Planners Asset Management, LLC first reported this position in Q2 2026.
How St. Louis Financial Planners Asset Management, LLC's ABT position evolved
St. Louis Financial Planners Asset Management, LLC first disclosed a stake in ABT in Q2 2026 at 51,393 shares (US$4.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 51.39K | $4.90M | New |
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 216 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), BlackRock Inc (US$13.84B), VANGUARD CAPITAL MANAGEMENT LLC (US$10.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- BlackRock Inc 152.56M sh · $13.84B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 113.75M sh · $10.32B · Q2 2026
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 49.02M sh · $4.45B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 39.22M sh · $3.54B · Q2 2026
- Geode Capital Management 39.22M sh · $3.54B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026